Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
Titel:
Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial
Auteur:
Rovati, L.C. Brambilla, N. Blicharski, T. Connell, J. Vitalini, C. Bonazzi, A. Giacovelli, G. Girolami, F. D'Amato, M.